Billionaire Herriot Tabuteau's Axsome wins FDA acceptance for narcolepsy drug
Billionaires Africa | 16.07.2026 00:32
The U.S. Food and Drug Administration has accepted for review a new narcolepsy drug from Axsome Therapeutics, the biotech built by Haitian-born billionaire Herriot Tabuteau, advancing a treatment that forms part of his plan to file a new medicine every year through 2030.
